色多多下载官方版_色多多app最新版下载_色多多深夜福利免费观看_色多多网站入口官方版下载

TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
Press disease charging rules announced at the end of June this year is expected to lower its cost
 
Author:中國(guó)銘鉉 企劃部  Release Time:2017-2-20 9:43:19  Number Browse:783
 
Medical network - February 16 press disease charging scope will expand further, the national development and reform commission website recently published "about push press disease charging work notice (sent to change price [2017] 2017) (hereinafter referred to as the" notice "), announced that press disease to charge in 2011 pilot basis to further expand the scope, has been clear about the detailed for around 320. "Notice" gave out a clear timetable - city public hospital comprehensive reform pilot area is carried out by the end of 2017 the diseases were diseases fee not less than 100, press disease to plant around the charge of the detailed rules for the implementation in 2017 by the end of June to the public and organize their implementation. Industry thinks, collect fees by diseases will be further compressed water prices, but pricing will affect the level of medical services, subject to government departments to strengthen supervision. 
 
At the end of June will be released detailed rules for the implementation 
 
The "notice" by the national development and reform commission jointly with planning, human resources social security by a coalition. "Notice" pointed out that, in accordance with the requirements for deepening the reform of medical health system deployment and, in 2011 countries launched the press disease pricing reform pilot work, actively choose some diseases to pilot and achieved initial results, to regulate the behavior of diagnosis and treatment and control unreasonable medical expenses growth has played a positive role. 
 
Around the "notice" requirements, to be on the basis of previous pilot reforms, further expand the number of diseases, is paid by the disease focus on clinical pathway, treatment effect is a common disease and frequently encountered disease in clear field press disease charging work, encourage ambulatory surgery should be brought into the press disease charge range. Level 2 and above around the implementation of public hospital is to choose a certain number of diseases press disease to collect fees, city public hospital comprehensive reform pilot area before the end of 2017 a disease is paid by the disease to no less than 100. Around must advance to formulate detailed rules for the implementation is paid by the disease, in 2017 by the end of June to the public and organize their implementation. 
 
Around the "combination of early clinical path management pilot and disease, according to the clear diagnosis, curative effect is mature technology, fewer complications, and the principle, we selected 320 diseases, used for charge in advance according to disease around." "Notice" pointed out that the technical specification of related diseases, society or association will entrust the relevant industry, unified release, as a push press disease to plant around the charge reform, to formulate charge standard reference. Can be published in the national 320 diseases around within the scope of choice, can also according to local actual to identify a specific disease. 
 
According to the disease to charge is expected to lower its cost 
 
It is understood that at present our country medical treatment charge mode is mainly according to the medical service project, refine the expenses for the diagnosis, treatment, check on each project. But in driven by economic interests, the charging mode has also led to excessive, excessive examination etc. Phenomenon, the phenomenon of repeated examination is very common. 
 
Public information, the concept of single diseases was introduced into China in the early 1980 s, many areas across the country had been started in 2011 pilot press disease to pay. Such as, new farming in anhui province in 2011 to 65 groups of major diseases to implement macro-reforms; Henan province choose 30 common disease, in the 30 hospitals in macro-reforms pilot, etc. 
 
The personage inside course of study points out, compared to 2011 in more 104 macro-reforms, joint mandate the three departments, not only to expand the scope of charge of single diseases, further to refine by macro-reforms of standard. 
 
"Notice" pointed out that the press disease shall manage the ceiling price charge standard in principle. Press disease charging standards contain what happened during the period of hospitalization diagnosis and treatment of patients with full cost, that is, from patients admitted to hospital, according to the disease treatment process accepted standardized diagnosis and treatment the curative effect of standard finally achieved discharged from the hospital, that take place in the whole process of diagnosis, treatment, surgery, anesthesia, inspection, care, and beds, medicines, medicinal materials and other various fees. Outside the disease expenses shall not charge separately, shall not be admitted to hospital after the inspection fees to outpatient service charge. 
 
"Notice" also stressed that "press disease to charge into the public medical institution performance evaluation system, set up according to the disease to charge for supervision and evaluation mechanism, determine the scientific and reasonable evaluation index, make full use of information technology, strengthen the disease cost change, service efficiency, service quality evaluation and supervision. Medical institutions must not shuffle, seriously ill patients should not shorten the length of hospital stay, decomposition in patients hospitalized times." 

 
Previous article:Lipid control market continues to grow Statin drug leads
Next article:Chronic disease prevention and control of medium and long-term planning issue preferable related generics
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粵公網(wǎng)安備 44011202000029號(hào)